Search Results for 'Sofosbuvir Daclatasvir'

Sofosbuvir Daclatasvir published presentations and documents on DocSlides.

Overcoming Patent barriers to hepatitis C treatment

karlyn-bohler
0 Slides

. The Hepatitis C Treatment Revolution . Expandi...

Access and affordability – Hepatitis C

olivia-moreira
0 Slides

Suzanne Hill . IPC. , December 2015. acknowledge...

May 3, 2016: Hepatitis C Kills More Americans than Any Other Infectious

luanne-stotts
0 Slides

Disease. Annual Hepatitis . C-related mortality i...

2014: HIV, HCV, and HBV

kittie-lecroy
0 Slides

Update. David Spach, MD. Professor of Medicine,...

HCV Clinical Management TRAINER(S)

danika-pritchard
0 Slides

IAPAC African Regional Capacity-Building Hub. Bas...

Daclatasvir Plus Sofosbuvir With or Without Ribavirin in Patients With HCV Genotype 3 Infection:

kittie-lecroy
0 Slides

Interim Analysis of a French Multicenter Compassi...

Description of Antivirals for Hepatitis C

conchita-marotz
0 Slides

LCDR Dwayne David, . PharmD. , BCPS, NCPS. Cherok...

Hepatitis C: A New Era In Treatment And Cure

myesha-ticknor
0 Slides

Adam . Deising. , DO. LCDR MC USN. Director of . ...

Hepatitis C Imtiaz Alam, M.D.

olivia-moreira
0 Slides

Medical Director, Austin Hepatitis Center. 1. Hep...

Ledipasvir-Sofosbuvir Retreatment with HCV Genotype 1

danika-pritchard
0 Slides

NIAID Retreatment. Phase . 2a . Treatment. . Exp...

Andrew I. Aronsohn, MD Associate Professor of Medicine

alida-meadow
0 Slides

University of Chicago. Chicago, Illinois. Challen...

HCV Clinical Management TRAINER(S)

trish-goza
0 Slides

IAPAC African Regional Capacity-Building Hub. Bas...

Access and affordability – Hepatitis C

olivia-moreira
0 Slides

Suzanne Hill . IPC. , December 2015. acknowledge...

Sofosbuvir + Ribavirin to Prevent Post-Transplant HCV Recurrence

briana-ranney
11 Slides

Sofosbuvir + Ribavirin to Prevent Post-Transplan...

Design Sofosbuvir / velpatasvir

fullyshro
7 Slides

for 12 weeks in liver transplant recipients with g...

Management of Patients with Chronic Hepatitis C: The Route to Safe and Effective Care

webraph
50 Slides

Sameh W. Boktor, MD, MPH. Medical Epidemiologist. ...

Daclatasvir + Sofosbuvir + RBV in GT3

sophia2
9 Slides

. with Advanced Liver Disease. ALLY-3+ Study. Phas...

Last Updated: July 6 ,

jaena
35 Slides

2015. Treatment of Hepatitis C in Patients with Re...

Daclatasvir - Asunaprevir

queenie
9 Slides

-. Beclabuvir in GT1 Patients without Cirrhosis. U...

Treatment of Chronic Hepatitis C Virus Infection in Adults

tracy
28 Slides

www.hivguidelines.org. APRIL 2023. NYSDOH AIDS Ins...

Sofosbuvir + Ribavirin in HCV Recurrence

williams
8 Slides

Following Liver Transplantation. Phase 2. Charlton...

Andrew J. Muir, MD, MHS Chief, Division of Gastroenterology

badra
33 Slides

Duke University School of Medicine. Durham, North ...

Newly Approved Hepatitis C Virus Drugs: Approach to Initial Therapy

della
34 Slides

Kristen M. Marks, MD. Assistant Professor. Weill C...

Safety and Efficacy of Daclatasvir

tabitha
14 Slides

. Plus . Sofosbuvir. With or Without Ribavirin . ...

Sofosbuvir-Velpatasvir in Decompensated HCV Cirrhosis

ahmir
11 Slides

ASTRAL-4. Source: Curry MP, et al. N Engl J Med. 2...

Ledipasvir-Sofosbuvir + RBV in Decompensated Cirrhosis or Post-Liver Transplantation

ahmir653
10 Slides

SOLAR-2. Source: . Manns. M, et al. Lancet Infect...